Home ›› Back


Perspectives in Clinical Research

Table of Contents RSS Feed
2018| October-December  | Volume 9 | Issue 4  

Please wait, loading Google Map...

EDITORIAL  
Drug-resistant tuberculosis – A ticking time bomb! p. 153
Srikanth Krishnamurthy
[ABSTRACT]  [HTML Full text]  [PDF]
ORIGINAL ARTICLES Top
Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications p. 155
Pradeep Gadge, Roshani Gadge, Nikita Paralkar, Preeti Jain, Vrunda Tanna
[ABSTRACT]  [HTML Full text]  [PDF]
Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne p. 161
Swapnil Narayan Deshmukh, Vandana Avinash Badar, Manali Mangesh Mahajan, D Sujata Dudhgaonkar, Dharmendra Mishra
[ABSTRACT]  [HTML Full text]  [PDF]
Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot p. 165
Kiran Gordhanbhai Piparva, Gaurav Jansari, Anil P Singh
[ABSTRACT]  [HTML Full text]  [PDF]
REVIEW ARTICLES Top
Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices p. 170
Mohit Hans, Suresh Kumar Gupta
[ABSTRACT]  [HTML Full text]  [PDF]
Materiovigilance: An Indian perspective p. 175
Bikash Ranjan Meher
[ABSTRACT]  [HTML Full text]  [PDF]
INVESTIGATOR INSIGHTS Top
Investigator-initiated studies: Challenges and solutions p. 179
Mahanjit Konwar, Debdipta Bose, Nithya J Gogtay, Urmila M Thatte
[ABSTRACT]  [HTML Full text]  [PDF]
STATISTICS Top
Study designs: Part 1 – An overview and classification p. 184
Priya Ranganathan, Rakesh Aggarwal
[ABSTRACT]  [HTML Full text]  [PDF]
LETTER TO EDITOR Top
From “Glivec®” to “Prevnar 13®”: How strong is the Indian drug patenting system? p. 187
Gerard Marshall Raj
[ABSTRACT]  [HTML Full text]  [PDF]